Skip to main content

Pathology & Oncology Research

Ausgabe 2/2011

Inhalt (35 Artikel)

Research

Implication of RAF and RKIP Genes in Urinary Bladder Cancer

Apostolos Zaravinos, Maria Chatziioannou, George I. Lambrou, Ioannis Boulalas, Dimitris Delakas, Demetrios A. Spandidos

Research

Nucleometric Study of Anisonucleosis, Diabetes and Oxidative Damage in Liver Biopsies of Orthotopic Liver Transplant Recipients with Chronic Hepatitis C Virus Infection

Grace Guzman, Rohini Chennuri, Andras Voros, Redouane Boumendjel, Alberto Locante, Roshan Patel, Tibor Valyi-Nagy

Research

Integrating Functional MRI Information into Radiotherapy Planning of CNS Tumors-Early Experiences

Árpád Kovács, Lilla Tóth, Csaba Glavák, Ferenc Lakosi, Janaki Hadjiev, Gábor Bajzik, Csaba Vandulek, Imre Repa

Research

Involvement of c-Ski Oncoprotein in Carcinogenesis of Cholangiocacinoma Induced by Opisthorchis viverrini and N-nitrosodimethylamine

Thidarut Boonmars, Zhiliang Wu, Sirintip Boonjaruspinyo, Anucha Puapairoj, Butsara Kaewsamut, Isao Nagano, Somchai Pinlaor, Puangrat Yongvanit, Orasa Wonkchalee, Amornrat Juasook, Pakkayanee Sudsarn, Tuanchai Srisawangwong

Research

The Role of Viral Infections in the Development of Dilated Cardiomyopathy

Enikő Tátrai, István Hartyánszky Jr., András Lászik, György Acsády, Péter Sótonyi, Márta Hubay

Research

Combined Antitumor Effect of Ad-bFGF-siRNA and Ad-Vpr on the Growth of Xenograft Glioma in Nude Mouse Model

Biao Zhang, Xuequan Feng, Jinhuan Wang, Xinnu Xu, Na Lin, Hongsheng Liu

Research

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

Zdravko Mitrović, Ivana Ilić, Igor Aurer, Sandra Bašić Kinda, Ivo Radman, Snježana Dotlić, Radmila Ajduković, Boris Labar

Research

Pretreatment T Lymphocyte Numbers Are Contributing to the Prognostic Significance of Absolute Lymphocyte Numbers in B-cell Non-Hodgkins Lymphomas

Lajos Gergely, Andrea Váncsa, Zsófia Miltényi, Zsófia Simon, Sándor Baráth, Árpád Illés

Research

Expression of Thyroid Transcription Factor-1 in Malignant Pleural Effusions

Andras Khoor, Angela L. Byrd-Gloster, Santo V. Nicosia

Research

Are GSTM1, GSTT1 and CAG Repeat Length of Androgen Receptor Gene Polymorphisms Associated with Risk of Prostate Cancer in Iranian Patients?

Zahra Ousati Ashtiani, Sayed-Mohammad Hasheminasab, Mohsen Ayati, Bareto Sabah Goulian, Mohammad Hossein Modarressi

Research

Expression and Clinical Significance of FAK and Src Proteins in Human Endometrial Adenocarcinoma

Nikolaos A. Chatzizacharias, Constantinos Giaginis, Elisavet Gatzidou, Gerasimos Tsourouflis, Ioannis Sfiniadakis, Paraskevi Alexandrou, Stamatios E. Theocharis

Research

Does Lactoferrin Behave as an Immunohistochemical Oncofetal Marker in Bone and Cartilage Human Neoplasms?

Antonio Ieni, Valeria Barresi, Maddalena Grosso, Giuseppe Speciale, Michele A. Rosa, Giovanni Tuccari

Research

Polymorphisms in the MUC16 Gene: Potential Implication in Epithelial Ovarian Cancer

Houda Bouanene, Hassen Hadj Kacem, Leila Ben Fatma, Halima Ben Limem, Slim Ben Ahmed, Salwa Yakoub, Abdelhédi Miled

Research

Immunotoxicity Monitoring of Hospital Staff Occupationally Exposed to Cytostatic Drugs

Anna Biró, Zoltán Fodor, Jenő Major, Anna Tompa

Research

Open MR-Guided High-Dose-Rate (HDR) Prostate Brachytherapy: Feasibility and Initial Experiences Open MR-Guided High-Dose-Rate (HDR) Prostate Brachytherapy

Ferenc Lakosi, Gergely Antal, Csaba Vandulek, Arpad Kovacs, Gabor L. Toller, Istvan Rakasz, Gabor Bajzik, Janaki Hadjiev, Peter Bogner, Imre Repa

Research

Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer

Tibor Szarvas, Tobias Jäger, Markus Becker, Stephan Tschirdewahn, Christian Niedworok, Ilona Kovalszky, Herbert Rübben, Süleyman Ergün, Frank vom Dorp

Research

PHOSPHO-STAT5 Expression is Associated with Poor Prognosis of Human Colonic Adenocarcinoma

Yin-Ling Mao, Zhi-Wei Li, Chang-Jie Lou, Da Pang, Yan-Qiao Zhang

Research

Upregulation of Twist in Gastric Carcinoma Associated with Tumor Invasion and Poor Prognosis

Guo-Qing Ru, Hui-Ju Wang, Wen-Jun Xu, Zhong-Sheng Zhao

Research

Prognostic Significance of p53 Protein Expression in Early Gastric Cancer

Andrea Rodrigues Gonçalves, Antonio Jose Vasconcellos Carneiro, Ivanir Martins, Paulo Antonio Silvestre de Faria, Maria Aparecida Ferreira, Eduardo Linhares Riello de Mello, Homero Soares Fogaça, Celeste Carvalho Siqueira Elia, Heitor Siffert Pereira de Souza

Research

The Effect of SYT-SSX and Extracellular Signal-Regulated Kinase (ERK) on Cell Proliferation in Synovial Sarcoma

Wenjuan Cai, Yan Sun, Wei Wang, Chunrong Han, Mamoru Ouchida, Wenbin Xia, Xiulan Zhao, Baocun Sun

Research

ADAM12 and ADAM17 Gene Expression in Laser-capture Microdissected and Non-microdissected Breast Tumors

Diana Narita, Edward Seclaman, Razvan Ilina, Natalia Cireap, Sorin Ursoniu, Andrei Anghel

Research

Identification of Signature Genes for Detecting Hedgehog Pathway Activation in Esophageal Cancer

Ling Yang, Yuehong Bian, Shuhong Huang, Xiaoli Ma, Chi Zhang, Xiulan Su, Zi-Jiang Chen, Jingwu Xie, Hongwei Zhang

Case Report

PET-CT Imaging and Reality

Zoltan Baliko, Veronika Sarosi, Miklos Balazs Illes, Zsuzsanna Varga, Geza Hegedus, Peter Molnar, Szabolcs Szakall

Case Report

Interdigitating Dendritic Cell Sarcoma Following Adult Liver Transplantation: Case Report and Literature Review

Xi Liu, Yuan Deng, Xuebin Zhang, Rajarshi Mukherjee, Wei Huang, Guanjun Zhang, Hongyan Wang, Xiaofeng Li

Case Report

Intestinal Langerhans Cell Histiocytosis-like Lesion in an Adult Presented with Diverticulitis: A Reactive or Neoplastic Condition?

Özgür Mete, Öner Doğan, Yersu Kapran, Deniz Tihan, Yeşim Erbil, Selçuk Özarmağan

Case Report

Malignancy or Inflammation? A Case Report of a Young Man with Fever of Unknown Origin

Mariann Harangi, Tibor Kovács, Éva Rákóczi, László Rejtő, László Mikó, László Tóth, Gabriella Szűcs, László Galuska, György Paragh

Case Report

Well-Differentiated Liposarcoma of the Oesophagus: Clinicopathological, Immunohistochemical and Array CGH Analysis

Jae Kyung Myung, Ji Bong Jeong, Daehee Han, Chi Sung Song, Hyeon Jong Moon, Young A. Kim, Ji Eun Kim, Sun-ju Byun, Woo Ho Kim, Mee Soo Chang

Case Report

A Rare Cause of Fever, Hepatosplenomegaly, and Thrombocytopenia: Hepatosplenic Gamma/Delta T-Cell Lymphoma

Murat Albayrak, Ozlem Sahin Balcik, Saadet Alan, Suleyman Lütfü Dıncer, Meltem Kurt Yüksel, Aynur Albayrak

Communication

Breast Cancer under 40 Years of Age: Increasing Number and Worse Prognosis

Ágnes Dobi, Gyöngyi Kelemen, László Kaizer, Roland Weiczner, László Thurzó, Zsuzsanna Kahán

Short Communication

Somatic Mutations of the Mixed-Lineage Leukemia 3 (MLL3) Gene in Primary Breast Cancers

Xin-Xin Wang, Liya Fu, Xuan Li, Xiao Wu, Zhengmao Zhu, Li Fu, Jin-Tang Dong

Short Communication

Application of Linear Discriminant Analysis and Attenuated Total Reflectance Fourier Transform Infrared Microspectroscopy for Diagnosis of Colon Cancer

Mohammadreza Khanmohammadi, Amir Bagheri Garmarudi, Simin Samani, Keyvan Ghasemi, Ahmad Ashuri

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.